Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 49651-49700 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05335148
Study to Evaluate the Safety of Colchicine
PHASE1
Recruiting
30 participants
Started: May 10, 2022 · Completed: Jun 1, 2024
1 condition
1 sponsor
3 locations
NCT06433830
Hetrombopag for the Thrombocytopenia Induced by Concurrent Chemoradiotherapy
PHASE2
Recruiting
50 participants
Started: May 10, 2022 · Completed: Jul 30, 2025
2 conditions
1 sponsor
1 location
NCT05274425
A 24-week rPMS Study in Real-world Setting for Enerzair
N/A
Recruiting
600 participants
Started: May 9, 2022 · Completed: Mar 11, 2027
1 condition
1 sponsor
16 locations
NCT05712668
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors
NA
Recruiting
100 participants
Started: May 9, 2022 · Completed: May 31, 2025
2 conditions
2 sponsors
1 location
NCT05206487
Hepatic Encephalopathy Prevention With Polydextrose After TIPS: Pilot Study (POEME)
NA
Recruiting
30 participants
Started: May 9, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT06363903
ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation
N/A
Recruiting
50 participants
Started: May 9, 2022 · Completed: May 31, 2025
6 conditions
3 sponsors
3 locations
NCT04400539
The IMmunotherapy Pleural 5-ALA PDT
PHASE2
Recruiting
20 participants
Started: May 9, 2022 · Completed: May 9, 2026
2 conditions
2 sponsors
1 location
NCT05442151
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
NA
Recruiting
200 participants
Started: May 9, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05260606
Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer
N/A
Recruiting
100 participants
Started: May 9, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05393388
Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study
N/A
Recruiting
160 participants
Started: May 9, 2022 · Completed: May 31, 2027
2 conditions
2 sponsors
1 location
NCT05130996
Observational Study Evaluating Safety and Performance of IDI Dental Implant Systems in Subjects Followed for 18 Months.
N/A
Recruiting
121 participants
Started: May 9, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05234463
Study of the Link Between Complement Activation and IgA Nephropathy Severity
N/A
Recruiting
400 participants
Started: May 9, 2022 · Completed: May 1, 2027
1 condition
1 sponsor
1 location
NCT05179954
Lipoprotein Kinetics in T1D
NA
Recruiting
30 participants
Started: May 9, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05217810
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
N/A
Recruiting
600 participants
Started: May 9, 2022 · Completed: Dec 23, 2026
1 condition
1 sponsor
18 locations
NCT05333627
Internet-delivered Cognitive Behaviour Therapy for Students: Duration Preference Trial
NA
Recruiting
200 participants
Started: May 9, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05072236
Effects of Adding Different Drugs for Preventing Cough Induced by Bronchoscopic Spraying of Local Anesthetics
NA
Recruiting
90 participants
Started: May 9, 2022 · Completed: Oct 30, 2024
3 conditions
1 sponsor
1 location
NCT05342441
Optimizing Graft Selection for ACL Reconstruction
NA
Recruiting
150 participants
Started: May 9, 2022 · Completed: May 31, 2028
1 condition
3 sponsors
1 location
NCT04832009
Reversing Glucose and Lipid-mediated Vascular Dysfunction
EARLY_PHASE1
Recruiting
46 participants
Started: May 9, 2022 · Completed: Aug 1, 2027
2 conditions
1 sponsor
1 location
NCT05427435
Feasibility of Ethanolization of Vein of Marshall With Specific Catheter in Atrial Fibrillation Ablation
NA
Recruiting
40 participants
Started: May 9, 2022 · Completed: May 30, 2027
1 condition
1 sponsor
1 location
NCT04650607
Phage Safety Cohort Study
N/A
Recruiting
100 participants
Started: May 9, 2022 · Completed: May 9, 2028
2 conditions
1 sponsor
1 location
NCT05327543
Effects of Online Yoga on the Quality of Life of Breast Cancer Patients
NA
Recruiting
138 participants
Started: May 9, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05134012
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
PHASE3
Recruiting
215 participants
Started: May 8, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
13 locations
NCT05350891
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
PHASE2
Recruiting
77 participants
Started: May 8, 2022 · Completed: May 8, 2026
1 condition
2 sponsors
8 locations
NCT05068349
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
PHASE4
Recruiting
300 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
7 conditions
1 sponsor
1 location
NCT05374252
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
PHASE3
Recruiting
102 participants
Started: May 7, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06458114
Feeling of Caregivers After a Palliative Management of Extreme Premature Babies in Delivery Room.
N/A
Recruiting
50 participants
Started: May 7, 2022 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT05505487
Construction and Effect Evaluation of Integrated Care Model for Pulmonary Infection in Stroke Patients With Tracheotomy
NA
Recruiting
80 participants
Started: May 7, 2022 · Completed: May 7, 2026
2 conditions
1 sponsor
1 location
NCT05294731
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
PHASE1/PHASE2
Recruiting
146 participants
Started: May 6, 2022 · Completed: Sep 30, 2027
9 conditions
1 sponsor
29 locations
NCT06063278
Step by Step Group Therapy for Bulimia Nervosa: Effectiveness and Mechanisms of Change.
NA
Recruiting
100 participants
Started: May 6, 2022 · Completed: Dec 20, 2025
1 condition
1 sponsor
1 location
NCT06516406
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
N/A
Recruiting
1,055 participants
Started: May 6, 2022 · Completed: May 31, 2032
3 conditions
1 sponsor
26 locations
NCT05801471
Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression
N/A
Recruiting
200 participants
Started: May 6, 2022 · Completed: Nov 6, 2025
1 condition
1 sponsor
2 locations
NCT05405374
OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
NA
Recruiting
101 participants
Started: May 6, 2022 · Completed: Oct 31, 2025
5 conditions
1 sponsor
9 locations
NCT04976881
Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
NA
Recruiting
840 participants
Started: May 6, 2022 · Completed: May 31, 2026
4 conditions
3 sponsors
1 location
NCT05759637
Type 2 Diabetes, Obesity and Cortisol Excess
N/A
Recruiting
3,200 participants
Started: May 6, 2022 · Completed: Dec 6, 2025
3 conditions
5 sponsors
5 locations
NCT06404840
Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
PHASE2
Recruiting
30 participants
Started: May 6, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05392088
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.
N/A
Recruiting
1,500 participants
Started: May 6, 2022 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT05287867
Trial for Treating Painful Degenerative Disc Disease
NA
Recruiting
42 participants
Started: May 6, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
2 locations
NCT05141513
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma
PHASE1
Recruiting
25 participants
Started: May 6, 2022 · Completed: Apr 30, 2028
1 condition
1 sponsor
1 location
NCT05334277
Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA
PHASE2
Recruiting
280 participants
Started: May 6, 2022 · Completed: Feb 29, 2028
1 condition
3 sponsors
26 locations
NCT05303415
Study of Low-intensity Focused Ultrasound Effects on Heat Evoked fMRI Signals
NA
Recruiting
80 participants
Started: May 6, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04848064
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
PHASE1
Recruiting
12 participants
Started: May 6, 2022 · Completed: Jan 30, 2026
4 conditions
1 sponsor
1 location
NCT05761470
Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation
PHASE2
Recruiting
66 participants
Started: May 6, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT06195462
Effects of Laying on of Hands in Fibromyalgia
NA
Recruiting
72 participants
Started: May 6, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05264818
Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
N/A
Recruiting
100 participants
Started: May 6, 2022 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT05310643
Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC
PHASE2
Recruiting
30 participants
Started: May 5, 2022 · Completed: Sep 30, 2027
1 condition
1 sponsor
9 locations
NCT00775476
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
PHASE2
Recruiting
290 participants
Started: May 5, 2022 · Completed: Sep 30, 2028
1 condition
9 sponsors
8 locations
NCT06263920
Neurofrailty: A Study of Late-onset Epilepsy and Its Associations
N/A
Recruiting
360 participants
Started: May 5, 2022 · Completed: Jan 12, 2027
3 conditions
1 sponsor
1 location
NCT05180825
Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy
PHASE2
Recruiting
134 participants
Started: May 5, 2022 · Completed: Dec 1, 2031
3 conditions
1 sponsor
25 locations
NCT04960579
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
PHASE1
Recruiting
231 participants
Started: May 5, 2022 · Completed: Dec 31, 2039
1 condition
2 sponsors
21 locations
NCT05301114
Social Risk Factors and Discrimination in Cancer Survivorship
NA
Recruiting
1,116 participants
Started: May 5, 2022 · Completed: Sep 30, 2026
5 conditions
4 sponsors
1 location
Previous
1
More pages
991
992
993
994
995
996
997
More pages
1333
Next